Literature DB >> 9449085

Laparoscopic resection of gastric leiomyosarcoma.

D T Dempsey1, I A Kelberman, M A Dabezies.   

Abstract

Wedge resection with a normal margin of stomach is generally considered adequate therapy for gastric leiomyosarcoma. We report here four patients with gastric leiomyosarcoma managed laparoscopically. The technique is described. There were no operative complications and all patients have been followed for 7 to 56 months. Three patients are free of disease and one patient with a high grade tumor is alive with liver metastases at 2 yars postoperatively. From this experience we conclude the following: 1) Laparoscopic wedge resection of gastric leiomyosarcoma is straightforward and easily accomplished without violation of standard surgical oncologic principles. 2) Intraoperative endoscopy is helpful in locating and manipulating the tumor, and aids in ensuring lumenal adequacy and staple line integrity. 3) Preoperative localizing studies may be misleading and should not discourage laparoscopic evaluation and treatment.

Entities:  

Mesh:

Year:  1997        PMID: 9449085     DOI: 10.1089/lap.1997.7.357

Source DB:  PubMed          Journal:  J Laparoendosc Adv Surg Tech A        ISSN: 1092-6429            Impact factor:   1.878


  4 in total

1.  Laparoscopic wedge resection for benign gastric tumors.

Authors:  M Röthlin; O Schöb
Journal:  Surg Endosc       Date:  2001-05-14       Impact factor: 4.584

2.  Laparoscopic resection of gastrointestinal mesenchymal tumors located in the upper stomach.

Authors:  N Tagaya; H Mikami; K Kubota
Journal:  Surg Endosc       Date:  2004-07-30       Impact factor: 4.584

3.  Laparoscopic gastric wedge resection and prophylactic antireflux surgery for a submucosal tumor of gastroesophageal junction.

Authors:  Jeong Sun Lee; Jin-Jo Kim; Seung-Man Park
Journal:  J Gastric Cancer       Date:  2011-06-30       Impact factor: 3.720

4.  Laparoscopic wedge resection of gastric leiomyoma.

Authors:  Atul K Madan; Constantine T Frantzides; Ali Keshavarzian; Claire Smith
Journal:  JSLS       Date:  2004 Jan-Mar       Impact factor: 2.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.